In its 2007 report on Toxicity Testing in the 21st Century: A Vision and a Strategy, the US National Research Council (NRC) highlighted need for more rapid toxicity testing strategies in order to expand the coverage of the large number of chemicals for which toxicological data is lacking.
This need was further underscored by the NRC in its 2009 report Science and Decision: Advancing Risk Assessment, which recommended the use of formal value-of-information (VOI) techniques to evaluate alternative testing strategies. Hagiwara et al. (2022) recently developed VOI methods to evaluate the trade-offs between the cost, timeliness, and uncertainty reduction in toxicity testing.
These contributions suggest that while rapid alternative test methods may be subject to greater uncertainty than traditional more expensive animal tests of longer duration, having sufficient information to support risk decision making in a timely manner can result in a lower total social cost by avoiding pubic health impacts that can accrue when decisions are delayed pending the results of toxicity tests of longer duration. Although further VOI analyses are needed to reaffirm these findings under broader real-world toxicity testing scenarios, initial results appear to be supportive of alternative test methods that can provide cost-effective toxicity data in a timely manner.
Posted in RSI News
More RSI News
Risk of Myocarditis and Pericarditis
Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of…
Read News ItemQuinolones and risk of retinal detachment
Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel…
Read News ItemIAI climate change report
The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…
Read News ItemQuinolones and risk of acute liver failure
Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…
Read News Item